药业内科将在2026年消化疾病周上展示数字病理学AI. PharmaNest to present digital pathology AI at Digestive Disease Week 2026.

药业将在2026年消化疾病周上展示五篇关于其FibroNest平台的文章. PharmaNest will present five communications at Digestive Disease Week 2026 focusing on its FibroNest platform. 该公司强调其数字病理学和人工智能工具如何分析炎症性肠道疾病和酸性食管炎中的纤维化. The company highlights how its digital pathology and AI tools analyze fibrosis in inflammatory bowel disease and eosinophilic esophagitis. 这些方法旨在通过提供精确,可复制的组织分析来改善疾病理解和药物开发. These methods aim to improve disease understanding and drug development by offering precise, reproducible tissue analysis.